Apices Soluciones S.L.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Apices Soluciones S.L. - overview
Established
2009
Location
Madrid, -, Spain
Primary Industry
Pharmaceuticals
About
Apices Soluciones S. L. is a Contract Research Organization providing clinical research services to healthcare and pharmaceutical sectors, focusing on project design, clinical trials, data management, and medical writing for various therapeutic areas. Founded in 2009 and headquartered in Madrid, Spain, Apices Soluciones S.
L. focuses on delivering comprehensive clinical research services. The company has engaged in one deal, with its most recent funding round occurring on November 22, 2021. The CEO, Oscar Salamanca, leads the firm which has not reported any changes in business strategy or operations.
Apices Soluciones S. L. , operating as APICES CRO, provides a full suite of clinical research services that includes project design, clinical trials management, data management, pharmacovigilance, and medical writing. The firm focuses on addressing needs in various therapeutic areas, especially oncology, for a diverse clientele comprising large pharmaceutical companies, biotechnology firms, and healthcare providers, both in Europe and Latin America.
In the most recent year of 2023, Apices Soluciones S. L. reported a revenue of USD 8. 16 mn and an EBITDA of USD 3.
79 mn, generated through service contracts with healthcare organizations, pharmaceutical companies, and research institutions. Following the acquisition of a majority stake by Magnum Capital Industrial Partners on November 22, 2021, Apices Soluciones S. L. plans to enhance its offerings and expand internationally.
The company aims to leverage this new partnership to pursue acquisitions of complementary companies within Spain and Europe, furthering its growth strategy.
Current Investors
Magnum Capital Industrial Partners
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.apices.es
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Apices Soluciones S.L. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Apices Soluciones S.L. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.